{"id":"W4386268787","doi":"10.1093/oncolo/oyad223","title":"Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"OPKO Health; Clovis Oncology; Novavax; Karyopharm Therapeutics; INOVIO Pharmaceuticals; Sanofi; Abeona Therapeutics; Acorda Therapeutics; Pfizer","keywords":"Medicine; Melanoma; Adjuvant; Internal medicine; Adjuvant therapy; Systemic therapy; Oncology; Adverse effect; Immunotherapy; Clinical trial; Single Center; Progression-free survival; Retrospective cohort study; Stage (stratigraphy); Surgery; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001209917,0.0003332073,0.0004982235,0.000855981,0.0005689058,0.0006787559,0.0003061036,0.000438272,0.001974071],"category_scores_gemma":[0.001562492,0.0003579753,0.0005199515,0.001207961,0.0003760332,0.0005149433,0.0004961149,0.0004104622,0.0003489524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005662685,"about_ca_system_score_gemma":0.0006474458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001581384,"about_ca_topic_score_gemma":0.002660814,"domain_scores_codex":[0.9990768,0.000291679,0.0001517777,0.0002539086,0.0001289249,0.00009696116],"domain_scores_gemma":[0.997927,0.0004256128,0.0009923535,0.0001829792,0.0001813612,0.0002906517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007537169,0.0001607577,0.9966253,0.00004823663,0.0001283831,0.0003889751,0.00009144874,0.00003394567,0.0002963267,0.00001694116,0.0001034972,0.001352407],"study_design_scores_gemma":[0.000247142,0.001609168,0.9930767,0.00004390972,0.0002547919,0.002837537,0.0005124711,0.0002460036,0.0002049391,0.0000331008,0.0009191119,0.00001517461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998548,0.000738295,0.0001146308,0.00001832697,0.000003554635,0.00006319788,0.0002539276,0.000001890166,0.0002581407],"genre_scores_gemma":[0.9988403,0.000280614,0.0001486377,0.00004396562,0.00001559104,0.00005396762,0.0005242292,0.00000197389,0.00009077229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001974071,"threshold_uncertainty_score":0.006603956,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08479655175958822,"score_gpt":0.3904699091171679,"score_spread":0.3056733573575797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}